POINT BIOPHARMA GLOBAL INC. Increase (Decrease) in Accrued Liabilities
POINT BIOPHARMA GLOBAL INC. reported Increase (Decrease) in Accrued Liabilities of -$4.53 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued liabilities for the quarter ending 2023-09-30 was $4.64M, a 45.50% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued liabilities for the quarter ending 2023-06-30 was -$6.76M, a 392.86% decline year-over-year.
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued liabilities for the quarter ending 2023-03-31 was -$2.41M, a 269.47% decline year-over-year.
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was $6.74M, a 596.87% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued liabilities for fiscal 2022 was $13.67M, a 260.64% increase from fiscal 2021.
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued liabilities for fiscal 2021 was $3.79M, a 156.27% increase from fiscal 2020.
- POINT BIOPHARMA GLOBAL INC. increase (decrease) in accrued liabilities for fiscal 2020 was $1.48M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | $4.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$2.12M derived: sum of 2 quarters · filed 2023-11-13 | -$4.53M 10-Q · filed 2023-11-13 | $2.21M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2023-06-30 | -$6.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$9.18M 10-Q · filed 2023-08-14 | -$2.44M derived: sum of 3 quarters · filed 2023-08-14 | $755.74K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2023-03-31 | -$2.41M 10-Q · filed 2023-05-15 | $4.33M derived: sum of 2 quarters · filed 2023-05-15 | $7.52M derived: sum of 3 quarters · filed 2023-11-13 | $9.83M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-12-31 | $6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $9.93M derived: sum of 2 quarters · filed 2023-11-13 | $12.24M derived: sum of 3 quarters · filed 2023-11-13 | $13.67M 10-K · filed 2023-03-27 | |||
| 2022-09-30 | $3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $5.50M derived: sum of 2 quarters · filed 2023-11-13 | $6.93M 10-Q · filed 2023-11-13 | $6.94M 10-Q · filed 2022-11-14 | $7.89M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.73M 10-Q · filed 2023-08-14 | $3.78M 10-Q · filed 2022-08-12 | $4.70M derived: sum of 3 quarters · filed 2023-08-14 | $6.38M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $1.42M 10-Q · filed 2023-05-15 | $1.41M 10-Q · filed 2022-05-13 | $2.39M derived: sum of 2 quarters · filed 2023-05-15 | $4.07M derived: sum of 3 quarters · filed 2023-05-15 | $3.75M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $967.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $2.64M derived: sum of 2 quarters · filed 2023-03-27 | $2.32M derived: sum of 3 quarters · filed 2023-03-27 | $3.79M 10-K · filed 2023-03-27 | |||
| 2021-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.35M derived: sum of 2 quarters · filed 2022-11-14 | $2.82M 10-Q · filed 2022-11-14 | $3.08M 10-Q · filed 2021-11-12 | $3.84M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$320.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.15M 10-Q · filed 2022-08-12 | $2.17M derived: sum of 3 quarters · filed 2022-08-12 | $2.30M derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $1.47M 10-Q · filed 2022-05-13 | $642.23K 10-Q · filed 2021-04-29 | $2.49M derived: sum of 2 quarters · filed 2022-05-13 | $2.62M derived: sum of 3 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $1.15M derived: sum of 2 quarters · filed 2022-03-25 | $112.58K 10-K · filed 2021-03-04 | $1.48M 10-K · filed 2022-03-25 | |||
| 2020-09-30 | $127.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $458.99K 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $331.16K 10-Q · filed 2021-08-13 |